Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$85.37 - $115.44 $71,283 - $96,392
835 Added 20.73%
4,863 $518,000
Q4 2023

Jan 17, 2024

BUY
$69.51 - $104.43 $2,919 - $4,386
42 Added 1.05%
4,028 $401,000
Q3 2023

Oct 30, 2023

SELL
$96.41 - $126.61 $48,012 - $63,051
-498 Reduced 11.11%
3,986 $412,000
Q2 2023

Jul 19, 2023

SELL
$118.5 - $160.53 $8,769 - $11,879
-74 Reduced 1.62%
4,484 $545,000
Q1 2023

May 02, 2023

BUY
$135.66 - $197.02 $14,379 - $20,884
106 Added 2.38%
4,558 $700,000
Q4 2022

Feb 02, 2023

SELL
$118.38 - $210.04 $15,507 - $27,515
-131 Reduced 2.86%
4,452 $800,000
Q3 2022

Oct 31, 2022

BUY
$118.07 - $194.18 $10,272 - $16,893
87 Added 1.94%
4,583 $542,000
Q2 2022

Aug 05, 2022

BUY
$117.13 - $176.59 $71,683 - $108,073
612 Added 15.76%
4,496 $642,000
Q1 2022

Apr 28, 2022

SELL
$126.46 - $235.05 $3.97 Million - $7.37 Million
-31,363 Reduced 88.98%
3,884 $669,000
Q2 2021

Jul 21, 2021

BUY
$129.91 - $234.98 $4.58 Million - $8.28 Million
35,247 New
35,247 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Abundance Wealth Counselors Portfolio

Follow Abundance Wealth Counselors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abundance Wealth Counselors, based on Form 13F filings with the SEC.

News

Stay updated on Abundance Wealth Counselors with notifications on news.